RXRX Today - Aug 12: Short Interest Rises
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
RXRX Today - Aug 12: Short Interest Rises
-
Letto da:
-
Di:
So, what happened? Recursion got smoked today. The stock took a hit, and it seems like traders were feeling pretty nervous. There was a lot of chatter about short interest rising to over 35%. That’s a big deal! When more people are betting against a stock, it can really shake things up. Plus, I saw some reports about folks buying up put options, which kinda signals that people were expecting more downside. Not a great vibe for the bulls.
Now, why did this happen? Well, it looks like there’s some concern about Recursion's growth. They’ve been pushing hard on their AI drug discovery partnerships, but even with that, they’re facing a cash burn and slow growth. That can freak investors out. Plus, there was some bearish sentiment floating around in the air, especially after a recent article pointed out that even with the Genentech news, there’s still a lot of skepticism about Recursion's future. Yeah, that one stung.
On the horizon, there’s a notice of proposed sale of securities under Rule 144. That could mean they’re looking to raise some cash, which is worth keeping an eye on. It’s like, more dilution might be coming down the line, and nobody loves that.
So, to wrap it up, Recursion had a tough day with a lot of noise about short selling and concerns over their growth strategy. It’s a wild ride in the biotech space, and RXRX is right in the middle of it. Just remember, this is all for fun and info—no financial advice here. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione